Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors.

Cui Y, Liu B, Luo S, Zhen X, Fan M, Liu T, Zhu W, Park M, Jiang T, Jin JS; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2011;6(7):e21896. doi: 10.1371/journal.pone.0021896. Epub 2011 Jul 21.

2.

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.

Apostolova LG, Hwang KS, Kohannim O, Avila D, Elashoff D, Jack CR Jr, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2014 Jan 4;4:461-72. doi: 10.1016/j.nicl.2013.12.012. eCollection 2014.

3.

Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification.

Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ.

Neurobiol Aging. 2011 Dec;32(12):2322.e19-27. doi: 10.1016/j.neurobiolaging.2010.05.023. Epub 2010 Jul 1.

4.

Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data.

Ye J, Farnum M, Yang E, Verbeeck R, Lobanov V, Raghavan N, Novak G, DiBernardo A, Narayan VA; Alzheimer’s Disease Neuroimaging Initiative.

BMC Neurol. 2012 Jun 25;12:46. doi: 10.1186/1471-2377-12-46.

5.

Multimodal classification of Alzheimer's disease and mild cognitive impairment.

Zhang D, Wang Y, Zhou L, Yuan H, Shen D; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Apr 1;55(3):856-67. doi: 10.1016/j.neuroimage.2011.01.008. Epub 2011 Jan 12.

6.

Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.

Da X, Toledo JB, Zee J, Wolk DA, Xie SX, Ou Y, Shacklett A, Parmpi P, Shaw L, Trojanowski JQ, Davatzikos C; Alzheimer's Neuroimaging Initiative.

Neuroimage Clin. 2013 Nov 28;4:164-73. doi: 10.1016/j.nicl.2013.11.010. eCollection 2014.

7.

Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.

Chincarini A, Bosco P, Calvini P, Gemme G, Esposito M, Olivieri C, Rei L, Squarcia S, Rodriguez G, Bellotti R, Cerello P, De Mitri I, Retico A, Nobili F; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Sep 15;58(2):469-80. doi: 10.1016/j.neuroimage.2011.05.083. Epub 2011 Jun 16.

PMID:
21718788
8.

Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion.

Westman E, Muehlboeck JS, Simmons A.

Neuroimage. 2012 Aug 1;62(1):229-38. doi: 10.1016/j.neuroimage.2012.04.056. Epub 2012 May 3.

PMID:
22580170
9.

Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.

Moradi E, Pepe A, Gaser C, Huttunen H, Tohka J; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Jan 1;104:398-412. doi: 10.1016/j.neuroimage.2014.10.002. Epub 2014 Oct 12.

PMID:
25312773
10.

Predicting missing biomarker data in a longitudinal study of Alzheimer disease.

Lo RY, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2012 May 1;78(18):1376-82. doi: 10.1212/WNL.0b013e318253d5b3. Epub 2012 Apr 4.

11.

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, McShane R.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Review.

PMID:
24913723
12.

Identification of Conversion from Normal Elderly Cognition to Alzheimer's Disease using Multimodal Support Vector Machine.

Zhan Y, Chen K, Wu X, Zhang D, Zhang J, Yao L, Guo X; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(4):1057-67. doi: 10.3233/JAD-142820.

PMID:
26401783
13.

CSF and brain structural imaging markers of the Alzheimer's pathological cascade.

Yang X, Tan MZ, Qiu A.

PLoS One. 2012;7(12):e47406. doi: 10.1371/journal.pone.0047406. Epub 2012 Dec 19.

14.

Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.

Willette AA, Calhoun VD, Egan JM, Kapogiannis D; Alzheimer׳s Disease Neuroimaging Initiative.

Psychiatry Res. 2014 Nov 30;224(2):81-8. doi: 10.1016/j.pscychresns.2014.08.005. Epub 2014 Aug 17.

15.

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.

Toledo JB, Weiner MW, Wolk DA, Da X, Chen K, Arnold SE, Jagust W, Jack C, Reiman EM, Davatzikos C, Shaw LM, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.

Acta Neuropathol Commun. 2014 Mar 6;2:26. doi: 10.1186/2051-5960-2-26.

16.

Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.

Ota K, Oishi N, Ito K, Fukuyama H; SEAD-J Study Group; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci Methods. 2015 Dec 30;256:168-83. doi: 10.1016/j.jneumeth.2015.08.020. Epub 2015 Aug 28.

PMID:
26318777
17.

Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using MRI and Structural Network Features.

Wei R, Li C, Fogelson N, Li L.

Front Aging Neurosci. 2016 Apr 19;8:76. doi: 10.3389/fnagi.2016.00076. eCollection 2016.

18.

Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.

Yu P, Dean RA, Hall SD, Qi Y, Sethuraman G, Willis BA, Siemers ER, Martenyi F, Tauscher JT, Schwarz AJ.

J Alzheimers Dis. 2012;32(2):373-85. doi: 10.3233/JAD-2012-120832.

PMID:
22796873
19.

Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts.

Schmand B, Eikelenboom P, van Gool WA; Alzheimer's Disease Neuroimaging Initiative.

J Am Geriatr Soc. 2011 Sep;59(9):1705-10. doi: 10.1111/j.1532-5415.2011.03539.x. Epub 2011 Aug 24.

PMID:
21883100
20.

Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment.

Schmand B, Eikelenboom P, van Gool WA; Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2012;29(3):641-8. doi: 10.3233/JAD-2012-111703.

PMID:
22297644

Supplemental Content

Support Center